ALSO NOTED

Related by string. * also . Also . ALso . Also : ALSO SINCE THE TRADES . GENERAL ARE ALSO SUBJECT . AND PROCEDURES ARE ALSO . ALSO SUBSCRIBE TO OUR . MAY ALSO BE OBTAINED . OS X. ALSO . Also En Vivo / n ot . N ot . not . noted . noting . Noting : DO NOT WARRANT THE . AND MAY NOT BE . DOW JONES IS NOT . IF YOU DO NOT . INCLUDING BUT NOT LIMITED . NOT REPRESENT ACTUAL TRADING * ALSO NOT RESOLD *

Related by context. Frequent words. (Click for all words.) 58 PHARMACEUTICALS 58 Guides FY# Quick Facts 57 Teva Pharma 56 FDA Clears 55 Premarket Movers 55 Posts Wider Loss 55 Premarket roundup 55 CFO resigns 55 REFILE UPDATE 1 55 RPT UPDATE 1 55 CORRECTED OFFICIAL 55 Drugmaker 55 earns rev 54 CORRECTED CORRECTED 54 Q1 Loss Widens 54 AGREEMENT WITH 54 TechMARK movers 54 Biopharm 54 Net Loss Narrows 54 Q2 Loss Narrows 53 Lowers Guidance 53 Q3 Loss Narrows 53 Earnings Scorecard 53 Q1 Loss Narrows 53 Q4 Profit Surges 53 Guides Below 53 Q4 Loss Narrows 53 CORRECTED CORRECTED UPDATE 53 EXPANDS 53 RESEARCH ALERT 53 Shares Slump 53 Movers Roundup 53 Guides Q4 53 CEO Exercises Options 52 Gets Approval 52 UNVEILS 52 Axcan Pharma 52 Q4 Loss Widens 52 4Q Loss Widens 52 Guides Above 52 Q3 Loss Widens 52 Finalizes Acquisition 52 Q3 Profit Surges 52 TO OFFER 52 Movers roundup 52 Regulators Approve 52 PROFILE CO 52 REFILE 52 CFO Resigns 52 Q2 Loss Widens 51 volatility Elevated 51 quotes/comstock/# * 51 Q1 Profit Declines 51 Posts 1Q 51 outlook disappoints 51 Sector Wrap 51 FY# Quick Facts 51 ImmunoCellular Therapeutics 51 BIOTECH 51 PRXL 51 #.#B [006] 51 PARTNERS WITH 51 Nearly Triples 51 PHARMA 50 ACQUIRES 50 #.#/shr [002] 50 Glance STOCKS NEWS EUROPE 50 TO ACQUIRE 50 Winning Streak Continues 50 AGREES TO 50 Analyst downgrades 50 Bay Biz Buzz 50 Posts Quarterly 50 Narrows Loss 50 BioDelivery Sciences 50 Idera Pharmaceuticals 50 Announces Organizational Changes 50 Annouces 50 #M [001] 50 BRIEF 50 Issues Statement Regarding 50 STOCKS NEWS US 50 Bayer Schering 50 AVEO Pharmaceuticals 50 Q2 Profit Declines 50 BID FOR 50 Secures Funding 49 Net Loss Widens 49 2nd qtr profit 49 Posts Strong 49 Reach Settlement 49 Revenues Decline 49 Q2 Quick Facts 49 Raises Outlook 49 TO CUT 49 BOOSTS 49 9M 49 APPROACHES NEW UPSIDE TARGET 49 3Q Profit Rises 49 Injects 49 Updates Guidance

Back to home page